AGR2 is an endoplasmic reticulum-resident protein disulfide isomerase with increased expression levels that are implicated in several cancers, including breast, ovarian, prostate, bladder, and pancreatic cancer [8, 11, 14–16, 32–37]. Here, AGR2 is linked to familial pancreatic carcinoma.